Sinovac Biotech Ltd (SVA) — Cash Flow Reinvestment Rate
Sinovac Biotech Ltd (SVA) has a Cash Flow Reinvestment Rate of 0.36x as of December 2023, reinvesting $52.75 Million (capex $52.75 Million ) from operating cash flow of $146.01 Million. See free cash flow generation of Sinovac Biotech Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinovac Biotech Ltd Cash Flow Reinvestment Rate (2007–2023)
Historical reinvestment intensity for Sinovac Biotech Ltd across 12 annual periods. For the full cash flow conversion analysis, see SVA cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Sinovac Biotech Ltd (2007–2023)
Year-by-year capital reinvestment analysis for Sinovac Biotech Ltd. See Sinovac Biotech Ltd (SVA) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 28.96x | $3.07 Billion | $106.02 Million | $145.69 Million | ▲ +11774.8% |
| 2021 | 0.24x | $3.74 Billion | $15.35 Billion | $719.98 Million | ▼ -42.9% |
| 2020 | 0.43x | $204.78 Million | $479.31 Million | $127.65 Million | ▼ -68.6% |
| 2019 | 1.36x | $53.08 Million | $39.07 Million | $10.63 Million | ▼ -65.0% |
| 2018 | 3.89x | $30.87 Million | $7.94 Million | $5.61 Million | ▲ +875.5% |
| 2017 | 0.40x | $23.81 Million | $59.76 Million | $11.91 Million | ▼ -93.3% |
| 2015 | 5.93x | $24.97 Million | $4.21 Million | $5.30 Million | ▲ +544.1% |
| 2013 | 0.92x | $5.13 Million | $5.58 Million | $5.13 Million | ▼ -17.0% |
| 2011 | 1.11x | $15.46 Million | $13.94 Million | $15.46 Million | ▲ +1142.9% |
| 2009 | 0.09x | $4.32 Million | $48.41 Million | $4.32 Million | ▼ -76.4% |
| 2008 | 0.38x | $3.98 Million | $10.50 Million | $3.98 Million | ▼ -33.8% |
| 2007 | 0.57x | $2.47 Million | $4.32 Million | $2.47 Million | — |